Finally, we identified potential novel biomarkers for the diagnosis of CeD, especially in the NK cell compartment (GZMA, GZMM, PRF1, TXNIP and TAGAP), that can be detected before the duodenal damage. This evidence concerns the gene GZMA and cranioectodermal dysplasia.